BRIDG: a domain information model for translational and clinical protocol-driven research

Author:

Becnel Lauren B12,Hastak Smita3,Ver Hoef Wendy3,Milius Robert P4,Slack MaryAnn5,Wold Diane1,Glickman Michael L6,Brodsky Boris5,Jaffe Charles7,Kush Rebecca1,Helton Edward8

Affiliation:

1. Clinical Data Interchange Standards Consortium, Austin, TX, USA

2. Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA

3. Samvit Solutions LLC, Reston, VA, USA

4. National Marrow Donor Program, Minneapolis, MN, USA

5. Food and Drug Administration Office of Strategic Programs, Silver Spring, MD, USA

6. Computer Network Architects Inc. and ISO/TC 215 Health Informatics, Rockville, MD, USA

7. HL7 (Health Level 7 International), Ann Arbor, MI, USA

8. National Cancer Institute, Rockville, MD, USA

Abstract

Abstract Background: It is critical to integrate and analyze data from biological, translational, and clinical studies with data from health systems; however, electronic artifacts are stored in thousands of disparate systems that are often unable to readily exchange data. Objective: To facilitate meaningful data exchange, a model that presents a common understanding of biomedical research concepts and their relationships with health care semantics is required. The Biomedical Research Integrated Domain Group (BRIDG) domain information model fulfills this need. Software systems created from BRIDG have shared meaning “baked in,” enabling interoperability among disparate systems. For nearly 10 years, the Clinical Data Standards Interchange Consortium, the National Cancer Institute, the US Food and Drug Administration, and Health Level 7 International have been key stakeholders in developing BRIDG. Methods: BRIDG is an open-source Unified Modeling Language–class model developed through use cases and harmonization with other models. Results: With its 4+ releases, BRIDG includes clinical and now translational research concepts in its Common, Protocol Representation, Study Conduct, Adverse Events, Regulatory, Statistical Analysis, Experiment, Biospecimen, and Molecular Biology subdomains. Interpretation: The model is a Clinical Data Standards Interchange Consortium, Health Level 7 International, and International Standards Organization standard that has been utilized in national and international standards-based software development projects. It will continue to mature and evolve in the areas of clinical imaging, pathology, ontology, and vocabulary support. BRIDG 4.1.1 and prior releases are freely available at https://bridgmodel.nci.nih.gov.

Publisher

Oxford University Press (OUP)

Subject

Health Informatics

Reference45 articles.

1. FDA. Providing Regulatory Submissions in Electronic Format—Standardized Study Data: Guidance for Industry. 2014.http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM292334.pdf. Accessed December 21, 2016.

2. FDA. Study Data Technical Conformance Guide V3.0. 2016.http://www.fda.gov/downloads/ForIndustry/DataStandards/StudyDataStandards/UCM384744.pdf. Accessed December 21, 2016.

3. PMDA. Notification of Practical Operations of Electronic Study Data Submissions. 2015.http://www.pmda.go.jp/files/000206451.pdf. Accessed December 21, 2016.

4. PMDA. Technical Conformance Guide on Electronic Study Data Submissions. 2015.https://www.pmda.go.jp/files/000206449.pdf. Accessed December 21, 2016.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3